Skip to main navigation Skip to search Skip to main content

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

  • Ali Amin Al Olama
  • , Zsofia Kote-Jarai
  • , Fredrick R. Schumacher
  • , Fredrik Wiklund
  • , Sonja I. Berndt
  • , Sara Benlloch
  • , Graham G. Giles
  • , Gianluca Severi
  • , David E. Neal
  • , Freddie C. Hamdy
  • , Jenny L. Donovan
  • , David J. Hunter
  • , Brian E. Henderson
  • , Michael J. Thun
  • , Michael Gaziano
  • , Edward L. Giovannucci
  • , Afshan Siddiq
  • , Ruth C. Travis
  • , David G. Cox
  • , Federico Canzian
  • Elio Riboli, Timothy J. Key, Gerald Andriole, Demetrius Albanes, Richard B. Hayes, Johanna Schleutker, Anssi Auvinen, Teuvo L.J. Tammela, Maren Weischer, Janet L. Stanford, Elaine A. Ostrander, Cezary Cybulski, Jan Lubinski, Stephen N. Thibodeau, Daniel J. Schaid, Karina D. Sorensen, Jyotsna Batra, Judith A. Clements, Suzanne Chambers, Joanne Aitken, Robert A. Gardiner, Christiane Maier, Walther Vogel, Thilo Dörk, Hermann Brenner, Tomonori Habuchi, Sue Ingles, Esther M. John, Joanne L. Dickinson, Lisa Cannon-Albright, Manuel R. Teixeira, Radka Kaneva, Hong Wei Zhang, Yong Jie Lu, Jong Y. Park, Kathleen A. Cooney, Kenneth R. Muir, Daniel A. Leongamornlert, Edward Saunders, Malgorzata Tymrakiewicz, Nadiya Mahmud, Michelle Guy, Koveela Govindasami, Lynne T. O'Brien, Rosemary A. Wilkinson, Amanda L. Hall, Emma J. Sawyer, Tokhir Dadaev, Jonathan Morrison, David P. Dearnaley, Alan Horwich, Robert A. Huddart, Vincent S. Khoo, Christopher C. Parker, Nicholas Van As, Christopher J. Woodhouse, Alan Thompson, Tim Dudderidge, Chris Ogden, Colin S. Cooper, Artitaya Lophatonanon, Melissa C. Southey, John L. Hopper, Dallas English, Jarmo Virtamo, Loic Le Marchand, Daniele Campa, Rudolf Kaaks, Sara Lindstrom, W. Ryan Diver, Susan Gapstur, Meredith Yeager, Angela Cox, Mariana C. Stern, Roman Corral, Markus Aly, William Isaacs, Jan Adolfsson, Jianfeng Xu, S. Lilly Zheng, Tiina Wahlfors, Kimmo Taari, Paula Kujala, Peter Klarskov, Børge G. Nordestgaard, M. Andreas Røder, Ruth Frikke-Schmidt, Stig E. Bojesen, Liesel M. FitzGerald, Suzanne Kolb, Erika M. Kwon, Danielle M. Karyadi, Torben Falck Orntoft, Michael Borre, Antje Rinckleb, Manuel Luedeke, Kathleen Herkommer, Andreas Meyer, Jü rgen Serth, James R. Marthick, Briony Patterson, Dominika Wokolorczyk, Amanda Spurdle, Felicity Lose, Shannon K. McDonnell, Amit D. Joshi, Ahva Shahabi, Pedro Pinto, Joana Santos, Ana Ray, Thomas A. Sellers, Hui Yi Lin, Robert A. Stephenson, Craig Teerlink, Heiko Muller, Dietrich Rothenbacher, Norihiko Tsuchiya, Shintaro Narita, Guang Wen Cao, Chavdar Slavov, Vanio Mitev, Stephen Chanock, Henrik Gronberg, Christopher A. Haiman, Peter Kraft, Douglas F. Easton, Rosalind A. Eeles
  • Strangeways Research Laboratory
  • Institute of Cancer Research
  • University of Southern California
  • Karolinska Institutet
  • National Cancer Institute (NCI)
  • Cancer Council Victoria
  • University of Melbourne
  • University of Cambridge
  • Cancer Research UK Cambridge Institute
  • University of Oxford
  • University of Bristol
  • Program in Molecular and Genetic Epidemiology
  • American Cancer Society
  • Boston Veterans Affairs Healthcare System
  • Brigham and Women's Hospital
  • Harvard T.H. Chan School of Public Health
  • Imperial College London
  • University of Lyon
  • German Cancer Research Center
  • Washington University School of Medicine in St. Louis
  • NYU-Langone Medical Center
  • Tampere University
  • University of Turku and Turku University Hospital
  • Tampere University Hospital
  • Gentofte Hospital
  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • National Human Genome Research Institute (NHGRI)
  • Pomeranian Medical University in Szczecin
  • Mayo Clinic
  • Aarhus University
  • Queensland University of Technology
  • Menzies Health Institute Queensland
  • Viertel Centre for Research in Cancer Control
  • University of Queensland
  • University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
  • Medizinische Hochschule Hannover
  • Graduate School of Medicine
  • Cancer Prevention Institute of California
  • Stanford Cancer Institute
  • University of Tasmania
  • University of Utah School of Medicine
  • Edward Hines VA Medical Center
  • Inst. Portugues Oncologia
  • Medical University of Sofia
  • Second Military Medical University
  • Barts and The London School of Medicine and Dentistry
  • Moffitt Cancer Center
  • University of Michigan Medical School
  • Warwick Medical School
  • The Royal Marsden NHS Foundation Trust
  • National Institute for Health and Welfare
  • University of Hawaii Cancer Center
  • University of Sheffield
  • Department of Clinical Sciences, Danderyd Hospital
  • Johns Hopkins School of Medicine
  • Wake Forest School of Medicine
  • Helsinki University Central Hospital
  • Copenhagen University Hospital
  • Rigshospitalet
  • Huntsman Cancer Institute
  • Queensland Institute of Medical Research
  • University Hospital “Queen Johanna,”

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Abstract

Genome-wide association studies (GWAS) have identified multiple common genetic variants associated with an increased risk of prostate cancer (PrCa), but these explain less than one-third of the heritability. To identify further susceptibility alleles, we conducted a meta-analysis of four GWAS including 5953 cases of aggressive PrCa and 11 463 controls (men without PrCa). We computed association tests for approximately 2.6 million SNPs and followed up the most significantSNPs by genotyping 49 121 samples in 29 studies through the international PRACTICAL and BPC3 consortia. We not only confirmed the association of a PrCa susceptibility locus, rs11672691 on chromosome 19, but also showed an association with aggressive PrCa [odds ratio = 1.12 (95% confidence interval 1.03-1.21), P = 1.4 × 10-8]. This report describes a genetic variant which is associated with aggressive PrCa, which is a type of PrCa associated with a poorer prognosis.

Original languageEnglish
Article numberdds425
Pages (from-to)408-415
Number of pages8
JournalHuman Molecular Genetics
Volume22
Issue number2
DOIs
StatePublished - Jan 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease'. Together they form a unique fingerprint.

Cite this